The central nervous system (CNS) has specific barriers that protect the brain from potential 2 threats and tightly regulate molecular transport. Despite the critical functions of the CNS 3 barriers, the mechanisms underlying their development and function are not well understood, 4 and there are very limited experimental models for their study. Claudin 5 is a tight junction 5 protein required for blood brain barrier (BBB) and choroid plexus (CP) barrier structure and 6 function in humans. Here, we show that the gene claudin 5a is the zebrafish orthologue with 7 high fidelity expression, in the BBB and CP barriers, that demonstrates the conservation of the 8 BBB and CP between humans and zebrafish. Expression of claudin 5a correlates with 9 developmental tightening of the BBB and is restricted to a subset of the brain vasculature 10 clearly delineating the BBB. We show that claudin 5a expressing cells of the CP are ciliated 11 ependymal cells that drive fluid flow in the brain ventricles. Finally, we find that CP 12 development precedes BBB development and that claudin 5a expression occurs 13 simultaneously with angiogenesis. Thus, our novel transgenic zebrafish represents an ideal 14 model to study CNS barrier development and function, critical in understanding the 15 mechanisms underlying CNS barrier function in health and disease. 16 17 18 19 20 21
INTRODUCTION 1
The central nervous system is protected by three specialized barriers that shield the vulnerable 2 brain tissue from potential threats and actively regulate exchange of ions and nutrients. The 3 blood brain barrier (BBB) is formed by endothelial cells between blood and brain interstitial Swanson and McGavern, 2015) . Targeting the breakdown or dysfunction of the BBB in CNS 28 disease has significant potential as treatment target, but is severely hampered by a lack of 29 experimental models and current treatment is limited to broad spectrum 30 immunosuppression/anti-inflammatory treatment with, for example, glucocorticosteroids 31 (Obermeier et al., 2013) . Furthermore, to improve drug delivery in CNS disease specific 1 modulation of therapeutic delivery to the brain with limited neurotoxicity is critical (Greene 2 and Campbell, 2016), but there are very limited experimental models that allow the required 3 non-invasive imaging and mechanistic studies (Greene and Campbell, 2016; O'Keeffe and 4 Campbell, 2016; Zhang et al., 2010) . 5 In vitro experimental models exist to study different aspects of the BBB, but none of them can 6 completely mimic the complex interplay between BBB and other cells, such as immune cells or 7 pathogens. In addition, in vivo systems are often restricted by the use of a single method, like 8 single molecular tracer injections or immunohistochemistry. Moreover, real time in vivo 9 imaging of the BBB and CP is not possible in current models (Blanchette and Daneman, 2015) . 10 Therefore, we set out to develop and use a new model with the potential to understand the 11 mechanistic biology of the BBB and CP. The zebrafish (Danio rerio) model has proven to be highly accessible for real time imaging 14 especially in combination with fluorescently labelled tissues and is therefore extensively used 15 to study development and many aspects of human disease (Holtzman et al., 2016) . Zebrafish 16 possess a BBB and CP, similar to higher vertebrates, and Claudin 5a has been suggested to play 17 an essential role in establishment and maintenance of these barriers between systemic 18 circulation and CNS (Henson et al., 2014; Jeong et al., 2008; Xie et al., 2010) . Early in 19 development, at 14 hours post fertilization (hpf), claudin 5a is expressed in the entire 20 developing zebrafish CNS (Zhang et al., 2010) . However soon after, labelling is confined to the 21 CP and brain vasculature (from 20 hpf respectively 48 hpf onwards) (Xie et al., 2010; Zhang et 22 al., 2010) . Functional studies have shown size-dependent exclusion of fluorescent tracers 23 injected in the circulation from 2 dpf onwards indicative for the functional maturation of the 24 BBB shortly after TJ formation (Fleming et al., 2013; Jeong et al., 2008; van Leeuwen et al., 25 2014; Xie et al., 2010) . Furthermore, Claudin 5a has been suggested to be involved in the 26 establishment of the neuroepithelial ventricular barrier, which is essential for brain ventricle 27 expansion and subsequent brain development (Zhang et al., 2012 (Zhang et al., , 2010 . With the use of 28 several enhancer trap lines the presence of a diencephalic and myelencephalic CP has been 29 suggested to be present in zebrafish larvae early in development (Bill and Korzh, 2014; Bill et 30 5 al., 2008; García-Lecea et al., 2008; Henson et al., 2014) . Therefore, we considered Claudin 5a 1 to be an excellent candidate as the basis for our new in vivo model for the BBB and CP. In this study, we have identified and confirmed claudin 5a as the zebrafish gene equivalent to 4 human claudin 5. We have generated a claudin 5a reporter transgenic that has high fidelity of 5 expression in both the BBB and CP. Claudin 5a expressing cells in the CP are ciliated ependymal 6 cells that drive fluid flow early in development. Using our new transgenic we demonstrate that 7 the CP forms prior to expression of claudin 5a in brain blood vessels but that once the BBB is 8 established claudin 5a expression coincides with new BBB vessel formation. 
RESULTS

12
Zebrafish claudin 5a is the human claudin 5 orthologue 13 In order to identify the zebrafish (Dr) orthologue of human (Hs) protein Claudin 5 (cldn5 gene) 14 we used a BLASTP search of the zebrafish genome (GRCz10) using the protein sequence of Hs 15 Claudin 5. Two zebrafish proteins, Claudin 5a and Claudin 5b, were identified as being most 16 similar by protein sequence (56.9% and 54.8% identical respectively; Figure 1A ). Alignment of 17 the zebrafish protein sequences to the Hs sequence could not identify which of these two 18 proteins is the orthologue. Examination of the genomic region and closer gene relatives of 19 claudin 5a and 5b clearly showed that claudin 5a shared synteny with Hs cldn5 and that claudin 20 5b was only present in ray-finned fish (Figure 1B and C; data not shown). In addition, 21 examination of zebrafish expression patterns (Thisse et al., 2004) showed that claudin 5a was 22 expressed in the central nervous system ventricle region while claudin 5b had a cardiovascular 23 patterning. Together, we took this as sufficient evidence that claudin 5a was the correct target 24 gene and using BAC recombineering (Abe et al., 2011) we inserted EGFP at the translation start 25 site of the claudin 5a gene with approximately 200 Kb of flanking sequence to maximise fidelity 26 of EGFP expression to endogenous claudin 5a ( Figure S1 ). To study the developmental expression of claudin 5a in TgBAC(cldn5a:EGFP) vum1 larvae and 1 correlate this to previous performed immunohistochemical analysis (Xie et al., 2010; Zhang et 2 al., 2012) , we performed non-invasive imaging of the brain region of larvae daily between 1 3 and 9 days post fertilisation (dpf; Figure 2 ). As early as 24 hpf, GFP expression was observed in 4 the area of the myelencephalic choroid plexus (mCP) and diencephalic CP (dCP) ( Figure 2B , 5 arrows). The mCP consisted of a large sheet of cells covering the roof of the hindbrain ventricle 6 that developed into a compact cluster located in the midline of the larval head. In addition to 7 expression in both CPs, labelling in brain parenchyma, presumably co-localizing with 8 vasculature, and spinal cord was observed from 3 dpf onwards ( Figure 2D , arrow). Between 3 9 and 5 dpf claudin 5a expression rapidly expanded in the entire parenchyma and had covered 10 the complete CNS vasculature by 5 dpf ( Fig 2F) . Interestingly, strong labelling in the midline of 11 the larval head was observed ( Figure 2B , open arrow). This labelling appeared at the same time 12 as in both CPs, connecting these structures, but did not co-localize with blood vessels and was 13 sustained through development ( Figure 2J Figure S2 ). This expression was 16 only present during early development and disappeared in later larval stages (data not shown).
17
Collectively, our TgBAC(Cldn5a:EGFP) vum1 zebrafish had specific expression in brain vasculature 18 and both CPs labelling the BBB and blood-CSF barrier respectively.
20
Claudin 5a expression in brain vasculature rapidly expands between 3 dpf and 4 dpf 21 To study if Claudin 5a can be found in tight junctions of brain vasculature and therefore 22 represents the BBB, we injected our construct in the vascular specific reporter line Claudin 5a expression occurs prior to new BBB vessel formation 9
As stated above, we had identified that Claudin 5a was first present in the larger vessels. To determine the position of the claudin 5a expressing cells being a major component of the 28 blood-CP barrier, its localisation in respect to the vasculature was analysed in more detail.
29
Three-dimensional confocal analysis revealed that the ACeV and prosencephalic artery (PrA) 1 formed a vascular circuit early in development, which overlapped with claudin 5a expression 2 at the location of the dCP ( Figure 5A, B ). In the mCP in the roof of the hindbrain ventricle a The cells of the choroid plexus are a specialized type of ependymal cells, which line the brain 1 ventricles. To confirm the identity of our cldn5a:EGFP cells we stained for glutamylated tubulin 2 to label cilia. We could image single cilia from cldn5a:EGFP cells in the mCP and dCP as early as 3 2 dpf ( Fig 7A-D) . Only monociliated cells were found at all stages examined in the fore and hind 4 brain ( Fig. 7A-P) . We could determine the polarity of the cldn5a:EGFP cells on the basis of the 5 abundant labelling of glutamylated tubulin in the skin, which revealed that cilia project into the 6 brain ventricles (Figure 7 B 
20
We show that developmental expression of cldn5a:EGFP is restricted to, and starts in both CPs 21 and the midline at 1 dpf, thereby narrowing down the previously shown whole-mount in situ in respect to brain tissue. Blood vessel segments lacking claudin5a expression were all located 17 at the borders of the brain and in close proximity to meninges. Therefore, it is likely that these 18 vessels are located outside the parenchyma and do not possess a BBB. proteins is present at the initiation of angiogenesis in the CNS of mice with subsequent increase 30 of TJ functionality during embryogenesis (Daneman et al., 2010 (Daneman et al., , 2009 ). In the opossum, it has 31 been demonstrated that newly formed blood vessels possess functional properties from their 1 initiation (Ek et al., 2006) . Our study offers a possible mechanism for this, whereby new vessels 2 express claudin 5a immediately to form TJs, reflecting developmental steps observed in other 3 models and demonstrating how our transgenic will enable determination of TJ and BBB 4 specification and functionality.
5
The timespan between initial TJ expression and a functionally intact BBB was for long believed 6 to be the main reason for differences in BBB permeability at different ages. However, 7 considering that these events coincide, an alternative explanation is a prolonged permeability 8 of the barrier between blood and CP in mice (Ek et al., 2006; Saunders et al., 2012) . The last 9 decade it has become clear that the blood-CP barrier has more functions than solely CSF 10 production and makes significant contributions to brain homeostasis. Junctional, enzymatic 2008). In precision, our transgenic line corroborates and extends those findings and shows cells 20 originating from the roofplate express claudin 5a and develop into ciliated ependymal cells.
21
The treatment of CNS disease is severely impeded by an inability to modulate the entry and 22 exit of therapeutic compounds. Therefore, an improved understanding of the biology of the 23 BBB and blood-CP barrier is of essential importance to improve treatment. Claudin 5 is a 24 tempting target for manipulation, since many hydrophilic drugs prefer to cross the BBB via the The authors declare that they do not have any competing or financial interests. is essential for zebrafish brain ventricular lumen expansion. Proc Natl Acad Sci U S A 107, 
